CD226 Antikörper

Produktnummer ABIN7636282

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CD226 in WB. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für CD226 Antikörper (ABIN7636282)

Target: CD226

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD226 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Klon: D7

Produktdetails anti-CD226 Antikörper

Verwendungszweck: Monoclonal Antibody to Cluster Of Differentiation 226 (CD226)

Spezifität: The antibody is a mouse monoclonal antibody raised against CD226. It has been selected for its ability to recognize CD226 in immunohistochemical staining and western blotting.

Kreuzreaktivität: Schwein

Aufreinigung: Protein A + Protein G affinity chromatography

Immunogen: RPB669Hu01Recombinant Cluster Of Differentiation 226 (CD226)

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.01-2 μg/mL,Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu CD226

Target: CD226

Andere Bezeichnung: CD226

Hintergrund: DNAM1, PTA1, TLiSA1, DNAX accessory molecule 1

UniProt: Q15762

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints